Literature DB >> 7784335

Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.

M Nishikawa1, H Hirabayashi, Y Takakura, M Hashida.   

Abstract

Hepatic targeting of proteins utilizing the sugar-recognition mechanism was investigated in mice after intravenous injection. Five proteins with different molecular weights, i.e., bovine gamma-globulins (IgG), bovine serum albumin (BSA), recombinant human superoxide dismutase (SOD), soybean trypsin inhibitor (STI), and chicken egg white lysozyme (LZM), were modified with 2-imino-2-methoxyethyl 1-thiogalactoside to obtain galactosylated proteins (Gal-IgG, Gal-BSA, Gal-SOD, Gal-STI, and Gal-LZM). The numbers of galactose residues were 38, 20, 11, 6, and 5 for Gal-IgG, Gal-BSA, Gal-SOD, Gal-STI, and Gal-LZM, respectively. All galactosylated proteins were dose-dependently taken up by the liver and the relative amount accumulated in the liver was decreased with an increase of the administered dose. At low doses (0.05 and 0.1 mg/kg), Gal-IgG, Gal-BSA, and Gal-SOD could be taken up by the liver up to more than 70-80% of dose within 10 min after intravenous injection, but the maximum amounts accumulated in the liver were approximately 40 and 30% of the dose for Gal-STI and Gal-LZM, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784335     DOI: 10.1023/a:1016222808484

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

Review 3.  Carbohydrate-specific receptors of the liver.

Authors:  G Ashwell; J Harford
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  Human hepatic lectin. Physiochemical properties and specificity.

Authors:  J U Baenziger; Y Maynard
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

5.  Disposition and tumor localization of mitomycin C-dextran conjugates in mice.

Authors:  Y Takakura; A Takagi; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

6.  Disposition characteristics of macromolecules in tumor-bearing mice.

Authors:  Y Takakura; T Fujita; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

7.  2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins.

Authors:  Y C Lee; C P Stowell; M J Krantz
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

8.  Disposition characteristics of protein drugs in the perfused rat kidney.

Authors:  K Mihara; T Hojo; M Fujikawa; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

9.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

10.  Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion.

Authors:  T Fujita; H Furitsu; M Nishikawa; Y Takakura; H Sezaki; M Hashida
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

View more
  8 in total

1.  Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.

Authors:  H Hirabayashi; M Nishikawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

Review 2.  Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.

Authors:  Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

3.  Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro.

Authors:  Yong Jin; Jun Li; Long-Fu Rong; Yuan-Hai Li; Lin Guo; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

Review 4.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

5.  Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.

Authors:  Aki Murao; Makiya Nishikawa; Chittima Managit; Joseph Wong; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

6.  Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.

Authors:  Emi Ishida; Chittima Managit; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 7.  In vivo kinetics and biodistribution analysis of neoglycoproteins: effects of chemically introduced glycans on proteins.

Authors:  Akihiro Ogura; Almira Kurbangalieva; Katsunori Tanaka
Journal:  Glycoconj J       Date:  2014-04-05       Impact factor: 2.916

8.  Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Authors:  Hidemasa Katsumi; Jun-Ichi Sano; Makiya Nishikawa; Keiko Hanzawa; Toshiyasu Sakane; Akira Yamamoto
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.